DE250401C - - Google Patents
Info
- Publication number
- DE250401C DE250401C DENDAT250401D DE250401DA DE250401C DE 250401 C DE250401 C DE 250401C DE NDAT250401 D DENDAT250401 D DE NDAT250401D DE 250401D A DE250401D A DE 250401DA DE 250401 C DE250401 C DE 250401C
- Authority
- DE
- Germany
- Prior art keywords
- vaccines
- passive
- plants
- omnivalent
- extracts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960005486 vaccine Drugs 0.000 claims description 32
- 241000196324 Embryophyta Species 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- 235000013601 eggs Nutrition 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000008034 disappearance Effects 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 description 18
- 239000000284 extract Substances 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 206010013023 diphtheria Diseases 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000003322 Coinfection Diseases 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 241000304886 Bacilli Species 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 231100000699 Bacterial toxin Toxicity 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000000688 bacterial toxin Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 229940031348 multivalent vaccine Drugs 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000002650 habitual effect Effects 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000031711 Cytophagaceae Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229960005097 diphtheria vaccines Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE250401C true DE250401C (en, 2012) |
Family
ID=508928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT250401D Active DE250401C (en, 2012) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE250401C (en, 2012) |
-
0
- DE DENDAT250401D patent/DE250401C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Noon | Prophylactic inoculation against hay fever | |
| DE4447677C2 (de) | Verfahren zur Herstellung eines Impfserums zur Immunisierung gegen Pseudomonas Aeruginosa-Infektionen | |
| DE69032207T2 (de) | Einführung von bakterien in ovo | |
| Sandhu | Immunogenicity and safety of a live Pasteurella anatipestifer vaccine in White Pekin ducklings: laboratory and field trials | |
| Riker et al. | Atypical and pathological multiplication of cells approached through studies on crown gall | |
| DE1198489B (de) | Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie | |
| DE69306934T2 (de) | Geflügelkrankheit verursachende neue bakterie und daraus stammender impfstoff | |
| DE250401C (en, 2012) | ||
| DE1792256B2 (de) | Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen | |
| DE191752C (en, 2012) | ||
| CH639280A5 (de) | Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom. | |
| DE261702C (en, 2012) | ||
| DE2034118A1 (en) | Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins | |
| DE814315C (de) | Verfahren zur Herstellung von Seren, Impfstoffen u. dgl. | |
| DE2141901A1 (de) | Verfahren zur Herstellung eines Vak zins | |
| DE434751C (de) | Verfahren zur Herstellung von Antigonorrhoe-Frischvakzinen | |
| DE2719547A1 (de) | Immunostimulin, verfahren zu dessen herstellung und seine verwendung zur krebsbekaempfung | |
| DE3043291A1 (de) | Vakzine gegen keuchhusten | |
| DE216310C (en, 2012) | ||
| DE1467849A1 (de) | Verfahren zur Herstellung von Vakzinen | |
| DE725294C (de) | Verfahren zur Herstellung eines Impfstoffes zur Vorbeugung und Heilung der Hundestaupe | |
| AT117206B (de) | Verfahren zur Herstellung von Impfstoffen. | |
| DE501693C (de) | Verfahren zur Herstellung von Tuberkuloseschutz- und -heilmitteln | |
| DE132608C (en, 2012) | ||
| US1547369A (en) | Scarlet-fever toxin and antitoxin and process for producing the same |